Proteogenomics analysis of non-coding region encoded peptides in normal tissues and five cancer types
Rong XiangiD, Leyao MaiD, Ming‐Yu YangiD, Zetian ZhengiD, Xiaofang CheniD, Fujian Jia, Fanfan XieiD, Fuqiang LiiD, Kui WuiD, Yafeng ZhuiD
Abstract
Previous proteogenomics studies have identified peptides encoded by non-coding sequences such as pseudogenes and long non-coding RNAs (lncRNAs) in healthy human tissues as well as in cancers. However, these studies are either limited to analyze only healthy or cancerous tissues, lacking direct comparison between them. In this study, we used an established proteogenomics analysis workflow to analyze proteomics data from 926 cancer samples of five cancer types and 31 different healthy human tissues. We observed the protein level expression of pseudogenes can be classified as ubiquitous or lineage expression. The ubiquitously translated pseudogenes are homologous to house-keeping genes. Our results suggest there is common mechanism underlying the translation of pseudogenes in both normal and tumors. Moreover, we discovered several translated non-coding genes such as DGCR5 and RHOXF1P3 that were up-regulated in tumors compared to normal. These translated pseudogenes imply the biological function of pseudogenes extends to protein level yet to be studied. Further, from the non-coding region encoded peptides specifically detected in tumors we have predicted a large number of potential neoantigens which can be developed as cancer vaccine.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltration
C. Tretter, N. de Andrade Kraetzig, … A. M. Krackhardt·bioRxiv·Sep 17, 2022
- Immunogenicity of non-canonical HLA-tumor ligands identified through proteogenomics
M. Lozano-Rabella, A. Garcia-Garijo, … A. Gros·Clinical Cancer ResearchPeer-reviewed·Feb 7, 2023
- Identification of a large class of cancer-germline microproteins as a source of immunotherapeutic targets
Marta E. Camarena, Covadonga Vara, … M. Mar Albà·bioRxiv·May 20, 2026
- ProGeo-neo: a Customized Proteogenomic Workflow for Neoantigen Prediction and Selection
Yuyu Li, Guangzhi Wang, … Lu Xie·BMC Medical GenomicsPeer-reviewed·Apr 1, 2020
- Thousands of novel unannotated proteins expand the MHC I immunopeptidome in cancer
T. Ouspenskaia, T. Law, … A. Regev·bioRxiv·Feb 12, 2020
- Proteogenomic analysis unveils the HLA Class I presented immunopeptidome in melanoma and EGFR mutant lung adenocarcinoma
Y. A. Qi, T. K. Maity, … U. Guha·bioRxiv·Aug 4, 2020